Showing 441 - 460 results of 66,196 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.15s Refine Results
  1. 441

    Table_5_Decrease of Clone Diversity in IgM Repertoires of HBV Chronically Infected Individuals With High Level of Viral Replication.pdf by Binbin Hong (9989819)

    Published 2021
    “…To investigate the characteristics of antibody repertoires in patients with chronic HBV infection, we performed Illumina sequencing and IMGT/HighV-QUEST analysis of B lymphocytes from healthy adults and the HBV carriers with high or low level of viral replication. …”
  2. 442

    Data_Sheet_1_Secondhand Smoke Decreased Excitability and Altered Action Potential Characteristics of Cardiac Vagal Neurons in Mice.PDF by Junqing Sun (4688998)

    Published 2021
    “…</p><p>Methods: Adult male mice were exposed to four weeks of filtered air or SHS (3 mg/m<sup>3</sup>) 6 h/day, 5 day/week. Using patch-clamp recordings on identified CVNs in brainstem slices, we determined neuronal excitability and AP characteristics with depolarizing step- and ramp-current injections.…”
  3. 443

    Table_1_Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity.docx by Matthias Vonmoos (759842)

    Published 2019
    “…The categorization of the two cocaine user groups was based on a combination of absolute (± 0.5 ng/mg) and relative (± 10%) changes in the cocaine hair concentration between baseline and the 1-year follow-up. …”
  4. 444
  5. 445
  6. 446
  7. 447
  8. 448
  9. 449
  10. 450
  11. 451

    Fig 5 - by Kellie J. Walters (10451329)

    Published 2023
    Subjects:
  12. 452

    Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

    Published 2024
    “…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log<sub>10</sub> within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”
  13. 453
  14. 454
  15. 455
  16. 456
  17. 457
  18. 458
  19. 459
  20. 460